The process of uplisting to NASDAQ started roughly 4 weeks ago. Nader said the company is under confidentiality agreements with Big Pharma. They are waiting to see the data. The clinical trial results will be good; it's just a matter of how good. In other words, leronlimab is a home run. It's just a question of how far over the fence the baseball travels.
If the clinical trial results meet the primary endpoint, the national media will be all over the story. Fox News and Fox Business News have already brought leronlimab to the public's attention as well as have other media outlets. The presssure on the FDA to approve leronlimab will be intense.
But not only media pressure, the public outcry will be intense. When people start demanding access to leronlimab, the FDA will fold. Governors, Senators, House Congressmen, even the Trump administration will demand that the FDA approve leronlimab if the agency doesn't do so on its own.
News 
Market Data 
Discover 
